Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

KAIST uses wireless neural chip to track brain changes in real time after Alzheimer's drug ...

27 October 2026 · By · Wire by Fusion42

Published

27 October 2026

Topic

opportunities

◆ Sectors

Medtech

◆ Geography

South Korea

◆ Source

Read at eurekalert.org →

◆ Verified

Fusion42 · 27 October 2026 · Fusion42 review

KAIST developed a wireless implantable neural chip that monitors acetylcholine changes in real time in animal brains after Alzheimer's drug administration, enabling continuous measurement and light-based nerve stimulation. This innovation supports research in drug action and closed-loop brain stimulation systems for brain diseases.

This Wire brief sits within Fusion42's coverage of Medtech.

◆ ◆ The Wire takeaway

You can now pursue brain drug testing with a wireless implant that tracks neurotransmitter changes in real time. This opens the door to developing adaptive neural therapies that adjust stimulation based on direct brain feedback.

◆ Coverage

1 source · 27 Oct 2026

◆ Related on Wire

◆ Topics

Medtechneurotechnologywireless-sensingbrain-drug-monitoringalzheimersimplantable-device